First human test for new liver drug pill
NCT ID NCT07251712
Summary
This early-stage study aims to understand how the body absorbs and processes a new tablet form of a drug called Aramchol. It will involve 32 healthy volunteers who will take single doses of the new tablet. Researchers will measure the drug levels in participants' blood over time to compare it to an older version of the drug and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.